Breaking News, Collaborations & Alliances

Amicus, Brammer Bio Enter Gene Therapy Devt. and Mfg. Collaboration

Supports clinical and commercial supply needs for multiple batten disease programs

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Amicus Therapeutics has entered a manufacturing collaboration with Brammer Bio, now a part of contract development and manufacturing organization (CDMO) Thermo Fisher Scientific. Thermo’s late-stage clinical and commercial-scale capabilities provides Amicus with immediate clinical and commercial manufacturing capabilities and capacity for the Amicus intrathecal AAV Batten disease gene therapy programs. Amicus has also established a plasmid supply network together with multiple long-term supply a...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters